2 ML sodium nitroprusside 25 MG/ML Injection — RxCUI 240793
RxNorm drug concept · Semantic clinical drug
RxCUI 240793
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
14 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI240793
Official name2 ML sodium nitroprusside 25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium nitroprusside 50 MG per 2 ML Injection; sodium nitroprusside 50 MG in 2 ML Injection; sodium nitroprusside 25 MG/ML per 2 ML Injection
FDA products mapped14
Package NDCs mapped14
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 2 ML sodium nitroprusside 25 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML sodium nitroprusside 25 MG/ML Injection
RxCUI 240793 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Nitroprusside
7476IN -
Sodium nitroprusside
9895PIN
-
Nitroprusside
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nitroprusside Injection
1666592SCDF -
Sodium nitroprusside Injection
2645967SCDFP -
Nitroprusside Injectable Product
1159833SCDG -
Sodium nitroprusside Injectable Product
2659550SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Nitroprusside Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium nitroprusside 25 MG/ML
1666591SCDC
-
Sodium nitroprusside 25 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sodium nitroprusside 25 MG/ML
SCDC · 1666591 -
Nitroprusside Injection
SCDF · 1666592 -
Sodium nitroprusside Injection
SCDFP · 2645967 -
Nitroprusside Injectable Product
SCDG · 1159833 -
Sodium nitroprusside Injectable Product
SCDGP · 2659550
📦 FDA Products & Package NDCs
14 products · 14 package NDCs
14 package NDCs map to RxCUI 240793 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 14335-0131-01 | 1 VIAL in 1 CARTON (14335-131-01) / 2 mL in 1 VIAL | sodium nitroprusside | Hainan Poly Pharm. Co., Ltd. | 2024-08-13 |
| 42571-0265-75 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42571-265-75) / 2 mL in 1... | SODIUM NITROPRUSSIDE | Micro Labs Limited | 2017-12-30 |
| 43598-0587-23 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-587-23) / 2 mL in 1... | Sodium Nitroprusside | Dr.Reddy's Laboratories Inc., | 2019-12-17 |
| 55150-0320-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-320-01) / 2 mL in 1... | SODIUM NITROPRUSSIDE | AuroMedics Pharma LLC | 2020-12-10 |
| 65145-0101-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65145-101-01) / 2 mL in 1... | Sodium Nitroprusside | Caplin Steriles Limited | 2025-10-29 |
| 67457-0839-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-839-02) / 2 mL in 1... | Sodium nitroprusside | Mylan Institutional LLC | 2018-08-10 |
| 67457-0999-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-999-02) / 2 mL in 1... | Sodium nitroprusside | Mylan Institutional LLC | 2020-10-05 |
| 70069-0261-01 | 1 VIAL in 1 CARTON (70069-261-01) / 2 mL in 1 VIAL | Sodium Nitroprusside | Somerset Therapeutics, LLC | 2018-08-17 |
| 70121-1189-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1189-1) / 2 mL in 1... | Sodium nitroprusside | Amneal Pharmaceuticals LLC | 2017-11-07 |
| 70436-0028-80 | 1 VIAL in 1 CARTON (70436-028-80) / 2 mL in 1 VIAL | sodium nitroprusside | Slate Run Pharmaceuticals, LLC | 2020-10-15 |
| 71288-0202-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-202-02) / 2 mL in 1... | Sodium Nitroprusside | Meitheal Pharmaceuticals Inc. | 2019-12-06 |
| 71839-0120-01 | 1 VIAL in 1 CARTON (71839-120-01) / 2 mL in 1 VIAL | Sodium Nitroprusside | BE Pharmaceuticals Inc. | 2021-07-12 |
| 72485-0105-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72485-105-01) / 2 mL in 1... | SODIUM NITROPRUSSIDE | Armas Pharmaceuticals Inc. | 2020-03-27 |
| 75907-0290-11 | 1 VIAL, SINGLE-DOSE in 1 CARTON (75907-290-11) / 2 mL in 1... | Sodium Nitroprusside | Dr.Reddy's Laboratories Inc., | 2025-12-01 |
Observed labelers:
Dr.Reddy's Laboratories Inc., (2) ·
Mylan Institutional LLC (2) ·
Amneal Pharmaceuticals LLC (1) ·
Armas Pharmaceuticals Inc. (1) ·
AuroMedics Pharma LLC (1) ·
BE Pharmaceuticals Inc. (1)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.